Introduction {#sec1}
============

The kidney contains multiple specialized cell types that have district physiological functions. During embryogenesis, the urogenital system, including the kidney, is derived from the intermediate mesoderm of the developing embryo ([@bib16; @bib35]). Formation of the definitive kidney or metanephros in mammals is initiated by reciprocal interactions between two tissues types, the ureteric bud and metanephric mesenchyme, starting around 10.5 days postcoitum (dpc) in the mouse ([@bib9; @bib11; @bib28; @bib36]). At this time, analysis of transcription factor expression distinguishes two morphologically distinct populations: a core of *Six2*-expressing (*Six2+*) mesenchyme, and an outer layer of *Foxd1*+ cells that likely emerge from a common *Osr1+* mesenchymal progenitor ([@bib23; @bib25; @bib30]). As the outgrowing ureteric bud enters this mesenchyme and branches, *Six2+* cells condense around the bud tip forming the cap mesenchyme, whereas *Foxd1+* cortical stromal cells make up the renal capsule and nephrogenic interstitium between the *Six2+* population and the outermost connective tissue (the presumptive renal fascia or Gerota's fascia) that surrounds the kidney and adrenal gland ([@bib8; @bib23; @bib26]).

The *Six2+* cap mesenchyme is a multipotent self-renewing nephron progenitor population ([@bib23]). In conjunction with ureteric branching, a ureteric epithelium-derived WNT9B signal induces a pathway of nephrogenesis within a subset of *Six2+* progenitors ([@bib7; @bib20; @bib32; @bib33]). Induced cells undergo an initial aggregation to form the pretubular aggregate. Subsequently, through a mesenchymal-to-epithelial transition, the pretubular aggregate transitions to the renal vesicle that undergoes a series of morphological transformations and patterning processes generating the main body of the nephron from the proximal glomerulus to the distal connecting segment.

The mature nephron, and its accompanying vascular network, is embedded within the cortical and medullary interstitium ([@bib29]). This comprises pericytes and mesangial cell types that are intimately associated with the general kidney vasculature and the specialized vasculature of the glomerular capillary loops, respectively ([@bib34; @bib41]), and interstitial fibroblast-like cells that are most prevalent within medullary regions of the mature kidney. Currently, the origins and interrelationships among these cell types are unclear, and the precise role of these stromal components in development, normal kidney function, and disease is poorly understood.

In this study, we have determined the fate map of the *Foxd1+* cortical stromal cells during kidney development in vivo in the mouse. These studies demonstrate that the *Foxd1+* cortical stroma is a multipotent self-renewing progenitor population for stromal cells in the kidney, giving rise to cortical and medullary interstitial cells, mesangial cells, and pericytes of the kidney. Interestingly, *Foxd1+* stromal progenitors and *Six2+* nephron progenitors form two mutually exclusive progenitor compartments shortly after the onset of ureteric branching. Prior to this stage, we observed a small but significant contribution of *Foxd1+* cells to the *Six2+* progenitor population. Our observations also suggest that the *Foxd1+* stromal progenitor and *Six2+* nephron progenitor populations temporally and spatially coordinate cellular differentiation. These data highlight the roles of distinct progenitor compartments in the assembly of the mammalian kidney.

Results {#sec2}
=======

Generation of *Foxd1-Cre* Knockin Mouse Alleles {#sec2.1}
-----------------------------------------------

During early stages of kidney development, *Foxd1* is specifically expressed in the cortical stroma of the nephrogenic zone ([@bib10; @bib15; @bib26]). To determine the fate map of this *Foxd1*-expressing (*Foxd1+*) population, we generated three *Foxd1-Cre* knockin alleles in the mouse, where e*GFPCre (Foxd1*^*GC/+*^*), eGFPCreER*^*T2*^ *(Foxd1*^*GCE/+*^*)*, and *CreER*^*T2*^ *(Foxd1*^*CE/+*^*)* transgenes were introduced into the 5′ UTR of the endogenous *Foxd1* locus ([Figure S1](#app2){ref-type="sec"} available online). These *Foxd1*-Cre knockin alleles ablate *Foxd1* function; however, mice heterozygous for these and previously described null alleles are phenotypically normal and fertile ([@bib15; @bib26]) (data not shown). The *GCE* and *CE* alleles allow tamoxifen-dependent regulation of Cre recombinase activity ([@bib19; @bib23]).

To validate transgene expression patterns of the *Foxd1-Cre* knockin alleles, we examined GFP expression in the developing kidney of *Foxd1*^*GC/+*^ and *Foxd1*^*GCE/+*^ embryos. In both lines, GFP expression was observed in the cortical stroma during kidney development ([Figure S2](#app2){ref-type="sec"}; data not shown). The nuclear FOXD1 protein colocalized with nuclear GFP in *Foxd1*^*GC/+*^ kidneys ([Figure S2](#app2){ref-type="sec"}I), whereas FOXD1 was surrounded by cytoplasmic GFP in *Foxd1*^*GCE/+*^ kidneys ([Figure S2](#app2){ref-type="sec"}J). These observations confirmed GFP expression in FOXD1+ cortical stromal cells in the *Foxd1-GC* and *Foxd1-GCE* alleles.

Genome-wide gene expression projects (GenePaint and GUDMAP) have documented *Foxd1* expression in the glomerulus at a low level at 14.5 dpc and at a higher level at 19.5 dpc ([Figures S3](#app2){ref-type="sec"}A and S3B) ([@bib14; @bib39]), and microarray analysis suggests podocytes as the likely cell source ([@bib6]). Although *Foxd1* mRNA appears to be expressed in most podocytes of maturing-stage glomeruli ([Figures S3](#app2){ref-type="sec"}A and S3B), a recent study showed that Cre recombination was observed only in a subset of podocytes in *Foxd1-eGFPCre* mice during kidney development ([@bib3]), indicating posttranscriptional regulation for *Foxd1* expression or different sensitivity of detection methods. Consistent with these findings, we detected expression of GFP and FOXD1 in a subset of both podocytes and parietal epithelial cells of maturing-stage glomeruli, but not in less-differentiated capillary loop-stage glomeruli, in the *Foxd1*^*GC/+*^ kidney at 15.5 and 18.5 dpc ([Figure S3](#app2){ref-type="sec"}B and S3C; data not shown). We observed *Foxd1-GFP* expression only in the cortical stroma, the visceral (podocytes), and the parietal epithelial cells of the glomerulus. No *Foxd1-GFP* expression was observed in any other tissues of the developing kidney. Thus, the *Foxd1-Cre* knockin alleles faithfully document endogenous FOXD1 expression.

*Foxd1+* Cells within the Cortical Stroma Show a Distinct Fate Map to that of *Six2+* Nephron Progenitors in the Cap Mesenchyme {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------

The fate map of the *Foxd1+* cortical stroma was compared to that of the *Six2+* cap mesenchyme. *Foxd1*^*GC/+*^ and *Six2-tetoff-eGFPCre* (*Six2*^*TGC/+*^) ([@bib23]) mice were intercrossed with mice carrying a *R26R*-*lacZ* reporter allele (*R26R*^*lacZ/+*^) ([@bib38]) to permanently label descendant cells from the *Foxd1+* cortical stromal and *Six2+* cap mesenchymal cells by β-galactosidase (β-gal) expression.

As expected from our previous study ([@bib23]), analysis of *Six2*^*TGC/+*^*; R26R*^*lacZ/+*^ kidneys at 14.5 dpc showed β-gal activity confined to the cap mesenchyme and all nephron epithelia including the renal vesicle, S-shaped body, nephron tubule, and visceral and parietal epithelia of the glomerulus ([Figures 1](#fig1){ref-type="fig"}A, 1C, and 1E). In striking contrast, *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ displayed a reciprocal pattern of β-gal activity restricted to the cortical stroma, cortical and medullary interstitium, and the glomerular mesangium region ([Figures 1](#fig1){ref-type="fig"}B, 1D, and 1F). At later stages, we also observed β-gal activity within podocytes of glomeruli at the maturing stage consistent with *Foxd1* expression within this population ([Figures S4](#app2){ref-type="sec"}A and S4C). A low-variable incomplete β-gal activity was observed in a subset of nephrons ([Figures 1](#fig1){ref-type="fig"}D and [S4](#app2){ref-type="sec"}E). Taken together, our observations suggest that the fate maps of *Six2+* cap mesenchyme and *Foxd1+* cortical stroma are largely distinct: the former contributing to nephron epithelial cells, and the latter to renal stromal cell types.

The low contribution of *Foxd1+* descendant cells to regions of the nephron epithelium, normally populated only by cells originating from the *Six2+* cap mesenchyme, outside of the *Foxd1+* visceral and parietal epithelia suggests a more complicated relationship among these stromal and nephron progenitor populations. There are three possible explanations for this result. First, *Foxd1* may be activated transiently in a variable pattern within multiple regions of a subset of maturing nephrons. A molecular heterogeneity of this kind seems unlikely given our knowledge of nephron patterning and function. Furthermore, even if *Foxd1* is transiently expressed in differentiating nephron epithelia, it is expected that such transient expression will result in a low level of Cre protein insufficient for DNA recombination. Second, there is a continual low-level contribution of *Foxd1+* cortical stromal cells to repopulate the *Six2+* nephron progenitors as kidney development proceeds. However, pulse labeling of *Foxd1+* cortical stromal cells in *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ kidneys by tamoxifen injections at 11.5, 12.5, or 14.5 dpc did not result in β-gal+ cells in the nephron epithelium perinatally ([Figures S4](#app2){ref-type="sec"}B, S4D, and S4F; data not shown), indicating that there is no contribution of *Foxd1+* cells to the nephron epithelial cells at these stages after the onset of kidney development.

Finally, in the initial separation of *Foxd1+* and *Six2+* lineages at the onset of kidney development, some plasticity may remain within *Foxd1+* cells such that they can secondarily convert to the *Six2+* lineage. Although we did not detect *Foxd1-GFPCre* transgene expression in the SIX2+ cap mesenchyme at 11.5, 12.5, and 15.5 dpc, β-gal+ descendant cells from the *Foxd1+* population were observed in the SIX2+ cap mesenchyme of *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ kidneys by 11.5 dpc ([Figure S5](#app2){ref-type="sec"}). β-gal+ SIX2+ cells were more frequently observed in the outer half of the SIX2+ population close to the cortical stroma (65.9% at 11.5 dpc \[n = 41\] and 57.1% at 12.5 dpc \[n = 21\]). Subsequently, although we never observed overlap of *Foxd1*-driven GFP expression and SIX2, the fraction of β-gal+ cells within the SIX2+ population increased significantly as nephrons differentiate between 12.5 and 15.5 dpc (1.53% ± 0.48% to 3.31% ± 0.16%, n = 3; p \< 0.05, unpaired t test) ([Figure S4](#app2){ref-type="sec"}I).

Together, our results indicate that there is a low transient reassignment within a *Foxd1+* cell type to *Six2+Foxd1−* nephron progenitors but likely only at the onset of kidney development. By 11.5 dpc, all *Six2+* and *Foxd1+* mesenchymal cells are restricted to mutually exclusive nephron and stromal lineages, respectively. The marginal contribution of *Foxd1+* descendants to the *Six2+* population results in a sporadic contribution to the nephrons of the mature kidney: most nephrons are unlabeled by mesenchymal *Foxd1+* descendants. Those that show a variable contribution likely reflect the proportion of these descendants in the nephron precursor, the renal vesicle. Our data cannot exclude the possibility of transient SIX2+ FOXD1+ cells at different time points that our methods cannot detect.

The *Foxd1+* Cortical Stroma Is a Stromal Progenitor Population {#sec2.3}
---------------------------------------------------------------

We further determined cell types derived from *Foxd1*+ cortical stromal cells at a molecular level. We examined *Foxd1+* cortical stroma-derived β-gal+ cells in *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ kidneys at 15.5 dpc using the following cell-type-specific markers: cytokeratin (KRT) (ureteric tip and collecting duct); LIV2 (capsule and the outermost connective tissue); Wilms tumor 1 (WT1) (cap mesenchyme, visceral epithelium/podocytes); platelet-derived growth factor (PDGF) receptor β (PDGFRB; interstitium, glomerular mesangium, and pericytes); FLK1 (endothelium); CDKN1C (P57KIP2; a subset of the medullary interstitium); F4/80 (EMR1; macrophages); and smooth muscle actin α (aSMA/ACTA2; smooth muscle) ([Figure 3](#fig3){ref-type="fig"}).

In the nephrogenic zone, all FOXD1+ cortical stromal cells were β-gal+, no overlap of β-gal+ cells was observed in KRT+ ureteric tip/stalk cells, and only rare β-gal+ cells were noted among the SIX2+ cap mesenchyme, as described above ([Figures 2](#fig2){ref-type="fig"}A--2C). LIV2 staining was observed in the two outermost tissue layers of the kidney: the surface connective tissue, and an underlying layer of the capsule ([@bib26]) (data not shown). Although β-gal+ cells were detected in the inner LIV2+ renal capsule, a subpopulation of the FOXD1+ cortical stroma, no β-gal+ cells were observed in the outermost LIV2+ connective tissue ([Figure 2](#fig2){ref-type="fig"}D). In the renal cortex, PDGFRB+ cells, including cortical interstitial cells, mesangial cells of the glomerulus, and pericytes outside of the glomerulus, were β-gal+, but FLK1+ endothelial cells were β-gal− ([Figures 2](#fig2){ref-type="fig"}E and 2F; data not shown). As expected, some *Foxd1+* maturing podocytes were labeled such that all podocytes were β-gal+ in the adult kidney (black arrowheads in [Figures 2](#fig2){ref-type="fig"}E, 2F, and [S4](#app2){ref-type="sec"}C; data not shown). In the renal medulla, a subset of medullary interstitial cells expressing CDKN1C+ (P57KIP2+) ([@bib42; @bib43]) was β-gal+ ([Figure 2](#fig2){ref-type="fig"}G), but F4/80+ macrophages were β-gal− ([Figure 2](#fig2){ref-type="fig"}H). Although SMA+ cells in the kidney were derived from *Foxd1+* cells, β-gal+ cells were not observed in the SMA+ smooth muscle of the ureter ([Figure 2](#fig2){ref-type="fig"}I). Importantly, we observed no evidence of direct *Foxd1* expression in cortical/medullary interstitial cells, mesangial cells, or pericytes. Taken together, these data suggest that *Foxd1+* cortical stromal cells contribute to stromal cells of the kidney including cortical and medullary interstitial cells, mesangial cells, and pericytes but that smooth muscle cells in the ureter have an independent origin ([@bib1; @bib3; @bib17; @bib18; @bib27; @bib40]).

Tempo-Spatial Patterns for Stroma Formation from the *Foxd1+* Cortical Stroma during Kidney Development {#sec2.4}
-------------------------------------------------------------------------------------------------------

To examine whether there is an ongoing commitment of *Foxd1*+ cortical stromal cells to stromal lineages, we used the tamoxifen-dependent *Foxd1-GCE* allele to label *Foxd1*+ cortical stromal cells at later stages of kidney development. We confirmed that the recombinase activity of the eGFPCreER^T2^ triple-fusion protein was completely tamoxifen dependent: no background recombination was detected without tamoxifen administration in the developing kidney ([Figures 3](#fig3){ref-type="fig"}A, 3E, 3I, 3M, and 3Q), as we previously observed with a *Six2-eGFPCreER*^*T2*^ allele ([@bib23]).

The *Foxd1+* cortical stromal cells of *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ embryos were labeled by tamoxifen induction at 10.5, 12.5, or 14.5 dpc. β-gal activity was observed at 19.5 dpc in stromal cells of the kidney in embryos from dams injected with tamoxifen at all time points ([Figures 3](#fig3){ref-type="fig"}B--3D and 3F--3H). However, whereas tamoxifen injection at 10.5 dpc resulted in β-gal+ stromal cells along the entire radial axis of the kidney from the cortex to inner medulla (papilla) ([Figures 3](#fig3){ref-type="fig"}J, 3N, and 3R), 12.5 dpc injections did not label cells in the tip of the inner medulla ([Figures 3](#fig3){ref-type="fig"}K, 3O, and 3S), and 14.5 dpc injections showed β-gal+ stromal cells limited to the cortical interstitium ([Figures 3](#fig3){ref-type="fig"}L, 3P, and 3T). These data indicate that *Foxd1+* cortical stromal cells continuously contributed to stromal lineages throughout kidney development and that there was a temporal restriction where later differentiating cells arising from the *Foxd1+* progenitor compartment were cortically restricted. Interestingly, the radial restriction of β-gal+ stromal cells was still evident in the adult kidney, suggesting that radial domains once established were relatively stable within stromal tissues of the mature kidney ([Figure S6](#app2){ref-type="sec"}).

The pulse labeling of *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ at 10.5, 12.5, and 14.5 dpc prior to FOXD1 expression in podocytes of maturing glomeruli did not label podocytes ([Figures 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}; data not shown), suggesting that podocytes are not derived from the *Foxd1+* cortical stroma. The β-gal expression in a subset of podocytes in *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ embryonic kidneys is due to *Foxd1-eGFPCre* activity directly in *Foxd1+* podocytes.

Coordinated Differentiation from Nephron and Stromal Progenitor Populations during Kidney Organogenesis {#sec2.5}
-------------------------------------------------------------------------------------------------------

Nephron formation also demonstrates a temporal restriction along the radial axis of the kidney ([@bib2]), suggesting that nephron and stromal progenitor populations may differentiate in a coordinated manner during kidney organogenesis. To test this possibility, we examined the cellular contributions from the *Six2+* cap mesenchyme and *Foxd1+* cortical stroma at different stages of kidney organogenesis. Because the differentiating loop of Henle of newly formed nephrons extends into the previously generated medullary interstitium, we analyzed podocytes and mesangial cells derived from the cap mesenchyme and cortical stroma, respectively, within the glomerulus, where temporal differentiation of the nephron and stromal compartments is maintained.

Tamoxifen induction at 14.5 dpc in *Six2*^*GCE/+*^*; R26R*^*lacZ/+*^ embryos resulted in β-gal activity in the cap mesenchyme and main body of the nephron in the renal cortex at 19.5 dpc, including nephrin+ (NPHS1+) podocytes of the less-differentiated capillary loop-stage glomerulus localized to the outer cortex ([Figures 4](#fig4){ref-type="fig"}B, 4F, 4J, and 4R). However, β-gal+ cells were not observed in the more differentiated glomeruli that formed at earlier developmental stages and are positioned deeper within the cortical region ([Figures 4](#fig4){ref-type="fig"}F, 4N, and 4V). A similar labeling and analysis of the *Foxd1+* cortical stroma in *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ kidneys resulted in β-gal activity in stromal tissues of the renal cortex, the PDGFRB+ mesangium of the capillary loop-stage glomerulus ([Figures 4](#fig4){ref-type="fig"}C, 4G, 4K, and 4S), but not maturing-stage glomeruli ([Figures 4](#fig4){ref-type="fig"}G, 4O, and 4W). To compare contributions from the *Six2+* cap mesenchyme and *Foxd1+* cortical stroma directly, both progenitor populations were labeled in *Six2*^*GCE/+*^*; Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ kidneys at 14.5 dpc. β-gal activity was observed in both nephrin+ (NPHS1+) podocytes and PDGFRB+ mesangial cells of the capillary loop-stage glomerulus, but not the maturing-stage glomerulus ([Figures 4](#fig4){ref-type="fig"}D, 4H, 4L, 4P, 4T, and 4X). As expected, no β-gal activity was detected in oil-injected, carrier controls ([Figures 4](#fig4){ref-type="fig"}A, 4E, 4I, 4M, 4Q, and 4U). These data suggest that differentiation of stromal cells from the *Foxd1+* progenitor population temporally and spatially coordinates with differentiation of the adjacent *Six2+* progenitor pool into nephrons.

*Foxd1+* Cortical Stromal Cells Are Maintained by Self-Renewal {#sec2.6}
--------------------------------------------------------------

To analyze the stromal progenitor population quantitatively, we performed fluorescence-activated cell sorting (FACS) analysis of *Foxd1-GFP+* cells in *Foxd1*^*GCE/+*^ kidneys to determine the cell number of *Foxd1*+ cells during early-to-mid stages of nephrogenesis. We observed that *Foxd1*+ cells in a single kidney undergo a 22.5-fold increase from 4,485 ± 1,081 cells at 11.5 dpc (n = 12) to 101,068 ± 13,004 cells at 14.5 dpc (n = 6). Podocyte labeling is insignificant at this time ([Figures 1](#fig1){ref-type="fig"}B and 1F); thus, the majority of *Foxd1+* cells at 14.5 dpc are within the cortical stroma that harbors *Six2+* nephron progenitors and *Ret+* ureteric epithelial progenitors ([@bib37]). Given a continual contribution of *Foxd1*+ progenitor cells to differentiated stromal derivatives, these data indicate an extensive expansion of the *Foxd1*+ stromal progenitor pool during kidney organogenesis.

To examine whether expansion of the *Foxd1*+ cell compartment occurs by self-renewal ([Figure 5](#fig5){ref-type="fig"}A) or through repopulation from external *Foxd1−* progenitor cells ([Figure 5](#fig5){ref-type="fig"}B), we performed a developmental pulse-chase experiment labeling *Foxd1+* cells at the onset of kidney development (10.5 dpc) and examined retention of β-gal-labeled cells in the *Foxd1+* stromal progenitors at birth (19.5 dpc). To determine the dynamics of Cre recombination activity, we injected 2 mg of tamoxifen into dams at 9.5 dpc, 1 day before the onset of *Foxd1* expression in the metanephric region ([@bib1; @bib30]). No β-gal+ cells were observed in the 19.5 dpc kidney ([Figures 5](#fig5){ref-type="fig"}C, 5F, 5I, 5L, and 5O), consistent with a time window of tamoxifen activity of less than 24 hr for this dose as we reported previously ([@bib23]). When tamoxifen was injected at 10.5 dpc, we observed a significant contribution of β-gal+ cells within the *Foxd1-GFP+* cortical stroma at 19.5 dpc ([Figures 5](#fig5){ref-type="fig"}E, 5H, 5K, 5N, and 5Q). Between 10% and 20% cells of *Foxd1-GFP+* cortical stromal cells were β-gal+ at 19.5 dpc with some variation between dams and even between littermates ([Figures 5](#fig5){ref-type="fig"}N and 5Q; data not shown). No β-gal+ cells were detected in any oil-injected controls ([Figures 5](#fig5){ref-type="fig"}D, 5G, 5J, 5M, and 5P), indicating that these data are absolutely tamoxifen dependent. Considering our observations that even over a brief period from 11.5 to 14.5 dpc, the number of *Foxd1*+ cells increases 22.5-fold and that stromal cells are continuously differentiating from the *Foxd1*+ progenitor population, collectively, the results are most consistent with self-renewal within the *Foxd1+* cortical stroma as the main driver for the maintenance and expansion of the stromal progenitor pool. Although we cannot exclude the minor contribution of *Foxd1−* cells to the cortical stroma, we did not observe a reduced contribution of labeled cells along the medullary and cortical interstitium ([Figure 5](#fig5){ref-type="fig"}H; data not shown), suggesting that any contribution from *Foxd1−* cells is not likely to constitute a substantive mechanism maintaining cortical stromal populations.

A *Foxd1+* Cell Can Give Rise to Multiple Stromal Cell Types {#sec2.7}
------------------------------------------------------------

To determine whether multiple interstitial cell types can arise from clonal labeling of a *Foxd1+* stromal progenitor cell ([Figures 6](#fig6){ref-type="fig"}A and 6B), we optimized dosages of tamoxifen for clonal analysis ([@bib23]). With injection of 0.1 mg tamoxifen at 12.5 dpc, we observed well-separated rare, tamoxifen-dependent β-gal+ clusters in the kidney at 19.5 dpc (1.95 ± 1.00 clusters per kidney; n = 20) ([Figures 6](#fig6){ref-type="fig"}C--6F), indicating that these rare clusters are likely derived from a single *Foxd1+* cortical stromal cell. We analyzed 13 such clusters in kidneys with 3 clonal clusters or less at 19.5 dpc. Within a cluster, β-gal+ cells were observed within a limited area along the cortico-medullary axis ([Figures 6](#fig6){ref-type="fig"}D and 6F), indicating that renal stromal cells do not actively change relative positions not only along the radial axis ([Figure 3](#fig3){ref-type="fig"}) but also along the planes perpendicular to the cortico-medullary axis of the developing kidney. Multiple cells exhibiting β-gal activity were observed in the zone of *Foxd1+* stromal progenitor cells, consistent with our earlier data on self-renewal of this population (white arrows in [Figure 6](#fig6){ref-type="fig"}G). In differentiated stromal tissues, β-gal activity was observed in the cortical interstitium, mesangium, and medullary interstitium within a single cluster ([Figures 6](#fig6){ref-type="fig"}F, 6G, and 6G′). Thus, *Foxd1+* cortical stromal cells likely contain a multipotent cell type capable of generating regionally diverse stromal cell types.

*Foxd1* Function Is Dispensable for Regulation of the Stromal Lineage {#sec2.8}
---------------------------------------------------------------------

The transcription factor *Foxd1* plays important roles in kidney development. In the absence of *Foxd1* function, the renal capsule formed abnormally, and the cap mesenchyme is thickened with retarded nephron differentiation ([@bib12; @bib15; @bib26]). Because *Foxd1* is expressed in the stromal progenitor population, it is possible that *Foxd1* regulates the stromal lineage during kidney development. To address this question, we examined the fate map of *Foxd1+* cortical stromal cells in the absence of *Foxd1* activity.

*Foxd1*^*GC/CE*^ mice displayed a similar phenotype to that previously described for *Foxd1* null mutant mice: the horseshoe kidneys containing the accumulated cap mesenchyme ectopically along the cortico-medullary axis, and the thickened capsule on the cortical surface ([@bib15; @bib26]). Thus, the creation of the targeted allele appears to phenocopy the existing *Foxd1* null mutants. When *Foxd1*^*GC/CE*^*; R26R*^*lacZ/+*^ kidneys were examined, we observed β-gal activity in a similar range of cell types within the 15.5 dpc kidneys to *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^controls with a single active *Foxd1* allele ([Figures 7](#fig7){ref-type="fig"}A and 7B). In the renal cortex, β-gal+ cells were detected in PDGFRB+ mesangial cells and pericytes ([Figures 7](#fig7){ref-type="fig"}C and 7D). No evidence was found for the additional contribution of β-gal+ cells to the *Six2+* nephron progenitor pool or to cells of the nephron, except for the expected contribution to late-stage WT1+ podocytes ([Figures 7](#fig7){ref-type="fig"}C, 7D, 7I, and 7J). β-gal+ cells were observed in the CDKN1C+ (P57KIP2+) renal medullary interstitium, the LIV2+ renal capsule, but not in the KRT+ collecting duct ([Figures 7](#fig7){ref-type="fig"}E--7J). Thus, *Foxd1* activity is dispensable for specification and differentiation of the stromal interstitial lineage within the mouse kidney.

Discussion {#sec3}
==========

The *Foxd1+* Cortical Stroma Demarcates the Stromal Progenitor Population during Kidney Organogenesis {#sec3.1}
-----------------------------------------------------------------------------------------------------

Our data indicate that *Foxd1+* cortical stromal cells contribute to renal cortical and medullary interstitial cells, mesangial cells, and pericytes of the mammalian kidney ([Figure 7](#fig7){ref-type="fig"}K). The origin of the kidney stromal cells is somewhat controversial. In the mouse, analysis of *Osr1+* intermediate and dorsal lateral plate mesoderm derivatives at 7.5--10.5 dpc showed that this population contributes to *Foxd1+* stromal progenitors and *Six2+* nephron progenitors. Thereafter, *Osr1* expression becomes restricted to the *Six2+* cells as the lineage boundary is established between *Six2+* and *Foxd1+* progenitor compartments ([@bib30]). In the chick, labeling studies have suggested a paraxial mesoderm origin for *Foxd1+* stromal progenitors ([@bib13]). If *Foxd1* demarcates stromal progenitors in both systems, these data may suggest species difference or alternate mechanisms for distinct subsets of *Foxd1+* cells.

Our analysis does not address whether the *Foxd1+* cortical stroma is a homogeneous population where all *Foxd1+* cells are stromal progenitor cells. Alternatively, the *Foxd1+* cortical stroma may be a heterogeneous population where only a subset of *Foxd1+* cells maintains a stromal-repopulating and broad differentiation capability. Indeed, the *Foxd1+* cortical stroma consists of a cortical LIV2+ capsule and a medullary LIV2− nephrogenic interstitium. The current study does not distinguish whether stromal progenitor cells exist in the capsule, nephrogenic interstitium, or both. Moreover, it is possible that each domain contains heterogeneous cells with different properties. Additional fate mapping for subdomains within the *Foxd1+* cortical stroma will be required to address these possibilities.

Distinct Multipotent Self-Renewing Progenitor Populations Direct Mammalian Kidney Organogenesis {#sec3.2}
-----------------------------------------------------------------------------------------------

Our data reinforce the critical cellular makeup and distinct developmental properties of the niche present at each branch tip of the developing ureteric tree in the mammalian kidney. Within the ureteric epithelium are the mitotically active *Ret+* progenitors whose renewal establishes new branch tips in the arborizing collecting duct system and whose commitment generates the maturing medullary and cortical stalks of the differentiating ureteric epithelial network ([@bib37]). Immediately adjacent to the ureteric branch tips lie the *Six2+* cap mesenchyme, a multipotent self-renewing progenitor population for the main body of the nephron. Our data demonstrate that the *Foxd1+* population that surrounds the *Six2+* domain is a distinct multipotent self-renewing progenitor population for renal stromal cells.

*Six2* and *Foxd1* expression correlates with distinct mesenchymal progenitor populations. Both genes are rapidly downregulated on commitment and movement of cells from the ureteric tip zone suggesting that expression of these markers, and maintenance of progenitor properties, is dependent on this cortical niche. Our observation of the lineage boundary between the *Six2+* cap mesenchyme-derived nephron epithelial compartment and *Foxd1+* cortical stroma-derived stromal compartment suggests that these cell types are largely independent progenitor pools from the onset of kidney organogenesis at 10.5 dpc, consistent with our previous observation from a clonal analysis of *Osr1+* metanephric mesenchyme cells at 9.5 dpc ([@bib30]). However, our cell fate analysis indicates that a fraction of cells transiently activates *Foxd1* in a cell that becomes a *Six2+* nephron progenitor. Thus, *Foxd1* activity does not appear to result in an irreversible commitment to a stromal progenitor fate, consistent with our analysis of *Foxd1* null kidneys. The factor(s) responsible for establishing these lineage boundaries is unclear, but a number of transcriptional regulators have been mapped to each of these cellular compartments in the developing kidney ([@bib5; @bib31]).

Throughout kidney organogenesis, the *Six2+* and *Foxd1+* cells are retained in the cortical niche. As the developing kidney grows outward, these progenitor populations leave behind differentiated derivatives, and the kidney grows along a radial medullary to cortical axis with less mature nephron and stromal cells in more cortical regions at all developmental stages. The cellular localization of progenitor compartments and their progressive commitment could facilitate the coordination of differentiation of the distinct nephron and stromal lineages during kidney organogenesis. Consistent with this view, pulse labeling shows corecruitment of cell types derived from *Six2+* and *Foxd1+* cells into distinct components of assembling glomeruli.

Recently, it was proposed that the outer and inner regions within the cap mesenchyme may have different properties ([@bib10]). *Foxd1+* descendant *Six2+* cells tend to localize in the outer half of the SIX2+ cap mesenchyme just after the onset of kidney development. Although this bias along the outer-inner axis in the cap mesenchyme decreases gradually, the fraction of *Foxd1+* descendant cells among the entire *Six2+* population increases during kidney development, though there is no evidence of additional *Foxd1*+ cell recruitment into the *Six2+* pool during these stages. These data indicate that *Foxd1+* descendant *Six2+* cells in the outer region closer to the capsule may differentiate into the nephron less frequently than *Six2+* cells lying closer to the ureteric epithelium, contrary to the recently proposed model where the outer cap mesenchymal cells differentiate, whereas the inner cap mesenchymal cells self-renew ([@bib10]). Alternatively, these *Foxd1+* descendant *Six2+* cells may have different properties from other *Six2+* cells in the outer cap mesenchyme in cell proliferation/death and/or migration.

The relationship between developmental progenitor compartments within the kidney and the precise origins of some mature cell types that include the vasculature, macrophage, smooth muscle, and neural-associated components remain less clear, although our previous data suggest that vascular cells in the kidney and smooth muscle cells around the ureter are derived from parts of the *Osr1+* intermediate mesoderm and lateral plate mesoderm at 8.5 dpc ([@bib30]). Our data also shed light on differences between the kidney and ureter. The ureter mesenchyme does not originate from the cap mesenchyme, cortical stroma, or ureteric bud. Consistent with this, the *Foxd1− Tbx18+* mesenchyme between the kidney and nephric duct at the onset of kidney development contributes to the ureter mesenchyme ([@bib1; @bib40]). Other evidence suggests a tail bud origin for these cells in the chick ([@bib4]), whereas the contribution of *Osr1+* cell derivatives from 8.5 to 10.5 dpc to this population in the mouse points to a possible dorsal lateral plate origin ([@bib30]). Fate mapping analysis using additional tissue-specific transgenes will define progenitor populations for these cell types in the future.

Experimental Procedures {#sec4}
=======================

Mouse Strains {#sec4.1}
-------------

Mice were generated and maintained as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. All animal work was performed under the oversight by an institutional review board at the Harvard Center for Comparative Medicine.

FACS Analysis {#sec4.2}
-------------

FACS analysis of kidney cells was performed as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Histology {#sec4.3}
---------

Histology on kidneys was performed as described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

X-Gal Staining {#sec4.4}
--------------

X-gal staining was performed as described previously ([@bib21; @bib22]). Details are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.

Immunofluorescence {#sec4.5}
------------------

Confocal immunofluorescence was performed as described previously ([@bib23; @bib24]). Details are described in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}.
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![The *Six2+* Cap Mesenchyme and *Foxd1+* Cortical Stroma Give Rise to Distinct Cellular Lineages of the Kidney\
β-gal-stained (blue) kidneys from *Six2*^*TGC/+*^*; R26R*^*lacZ/+*^ (A, C, and E), and *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ (B, D, and F) embryos at 14.5 dpc counterstained with eosin (pink).\
(A and B) Whole kidney.\
(C--F) Higher magnification of the nephrogenic zone (C and D) and renal cortex with glomeruli (E and F).\
a, adrenal gland; cd, collecting duct; ci, renal cortical interstitium; cm, cap mesenchyme; cs, cortical stroma; k, kidney; mi, renal medullary interstitium; ms, mesangium; nt, nephron tubule; pe, parietal epithelium; rv, renal vesicle; sb, S-shaped body; ue, ureter epithelium; um, ureter mesenchyme; ut, ureteric tip; ve, visceral epithelium (podocyte). Scale bars, 200 μm (A and B) and 50 μm (C--F).](gr1){#fig1}

![The *Foxd1+* Cortical Stroma Is a Progenitor Population for Stromal Tissues in the Kidney\
Confocal immunofluorescence images of *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ kidneys at 15.5 dpc with anti-β-gal staining (green).\
(A--D) Nephrogenic zone.\
(A) FOXD1 (red).\
(B) SIX2 (red). Black arrows indicate β-gal+ SIX2+ cap mesenchyme cells.\
(C) KRT (red).\
(D) LIV2 (red). White and black arrows indicate inner LIV2+ β-gal+ cells in the renal capsule and outer LIV2+ β-gal− cells in the connective tissue, respectively.\
(E and F) Renal cortex with glomeruli.\
(E) PDGFRB (red) and WT1 (blue). Yellow and white arrows indicate PDGFRB+ β-gal+ pericytes and mesangial cells, respectively.\
(F) FLK1 (red) and WT1 (blue). Yellow and white arrowheads indicate FLK1+ β-gal− vascular cells in the renal cortex outside of the glomerulus and within the glomerular tuft, respectively. Black arrowheads in (E) and (F) indicate WT1+ β-gal+ podocytes.\
(G and H) Renal medulla.\
(G) CDKN1C (P57KIP2, red) and KRT (white).\
(H) F4/80 (red).\
(I) Ureter with SMA (red).\
Scale bars, 50 μm.](gr2){#fig2}

![The *Foxd1+* Cortical Stroma Contributes to Stromal Tissues throughout Kidney Organogenesis\
β-gal-stained (blue) kidneys from *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ embryos at 19.5 dpc after three successive injections of oil vehicle only at 10.5, 12.5, and 14.5 dpc (A, E, I, M, and Q) or after a single injection of 2 mg tamoxifen at 10.5 dpc (B, F, J, N, and R), 12.5 dpc (C, G, K, O, and S), or 14.5 dpc (D, H, L, P, and T).\
(A--D) Whole-mount view.\
(E--T) Sections counterstained with eosin (pink).\
(E--H) Whole kidney.\
(I--L) Nephrogenic zone and renal cortex.\
(M--P) Outer renal medulla.\
(Q--T) Inner renal medulla (papilla). Arrows in (R) indicate β-gal+ interstitial cells in the inner medulla adjacent to the pelvic urothelial lining.\
a, adrenal gland; k, kidney. Scale bars, 500 μm (A--H) and 100 μm (I--T).](gr3){#fig3}

![*Six2+* Cap Mesenchymal Cells and *Foxd1+* Cortical Stromal Cells Differentiate in a Coordinated Manner\
Kidneys at 19.5 dpc from *Six2*^*GCE/+*^*; Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ mice with oil-only injection at 14.5 dpc (A, E, I, M, Q, and U), *Six2*^*GCE/+*^*; R26R*^*lacZ/+*^ with 6 mg tamoxifen at 14.5 dpc (B, F, J, N, R, and V), *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ with 6 mg tamoxifen at 14.5 dpc (C, G, K, O, S, and W), and *Six2*^*GCE/+*^*; Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ with 6 mg tamoxifen at 14.5 dpc (D, H, L, P, T, and X).\
(A--D) β-gal-stained (blue) whole-mount kidney.\
(E--P) β-gal-stained (blue) sections counterstained with eosin (pink).\
(E--H) Nephrogenic zone and renal cortex. Black arrows and white arrows indicate capillary loop-stage and maturing-stage glomeruli, respectively.\
(I--L) Capillary loop-stage glomerulus.\
(M--P) Maturing-stage glomerulus.\
(Q--X) Confocal immunofluorescence images with anti-β-gal (red), a podocyte marker anti-NPHS1 (nephrin, green), and a mesangium marker anti-PDGFRB (white).\
(Q--T) Capillary loop-stage glomerulus. Yellow arrowheads and yellow arrows in (R)--(T) indicate the β-gal+ NPHS1+ podocytes and β-gal+ PDGFRB+ mesangial cells, respectively.\
(U--X) Maturing-stage glomerulus.\
a, adrenal gland; ci, renal cortical interstitium; k, kidney; ms, mesangium; nt, nephron tubule; pe, parietal epithelium; pr, pericyte; ve, visceral epithelium (podocyte). Scale bars, 500 μm (A--D), 100 μm (E--H), and 25 μm (I--X).](gr4){#fig4}

![*Foxd1+* Cortical Stromal Cells Self-Renew\
(A and B) Models for maintenance of cortical stromal cells.\
(A) A pulse-labeled β-gal+ (blue) *Foxd1+* cortical stromal (cs) cell produces another β-gal+ *Foxd1+* cortical stromal cell, which results in retention of β-gal+ cells in the *Foxd1+* cortical stroma. Differentiated stromal cells (st) are β-gal+ cells along the cortico-medullary axis throughout kidney organogenesis.\
(B) A *Foxd1−* stromal precursor population (sp) that generates *Foxd1+* cortical stromal cells (cs) resides outside of the *Foxd1+* population. Contribution of β-gal− cells from the *Foxd1−* stromal precursor population (sp) dilutes the pulse-labeled β-gal+ (blue) cells in the *Foxd1+* cortical stroma (cs; light green). Only differentiated stromal cells (st) at early stages will be β-gal+ (blue) cells that will be seen in the inner medulla (papilla), but stromal cells in the renal cortex (st; dark green), which differentiate at later stages, will be β-gal−.\
(C--Q) *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ kidneys at 19.5 dpc after injection of 2 mg tamoxifen at 9.5 dpc (C, F, I, L, and O) and 10.5 dpc (E, H, K, N, and Q), and oil only at 10.5 dpc (D, G, J, M, and P).\
(C--E) Whole-mount β-gal-stained (blue) kidneys.\
(F--H) Sections of β-gal-stained (blue) kidneys counterstained with eosin (pink).\
(I--K) Higher magnification of the cortical region in (F)--(H), respectively. White arrows in (K) indicate multiple β-gal+ cells in the cortical stroma.\
(L--Q) Confocal immunofluorescence images with anti-GFP (green), anti-β-gal (red), with (L--N) or without (O--Q) Hoechst (blue) staining. White arrows in (N) and (Q) indicate β-gal+ GFP+ cortical stromal cells.\
a, adrenal gland; ci, renal cortical interstitium; cm, cap mesenchyme; k, kidney; ms, mesangium; nt, nephron tubule; pe, parietal epithelium; pr, pericyte; rv, renal vesicle; ve, visceral epithelium (podocyte). Scale bars, 500 μm (C--H) and 50 μm (I--Q).](gr5){#fig5}

![*Foxd1+* Cortical Stromal Cells Can Be Multipotent Stromal Progenitors\
(A and B) Models for developmental potential of *Foxd1+* cells.\
(A) A *Foxd1+* cortical stromal cell retains multipotency to differentiate into different stromal tissues.\
(B) Developmental potential of a *Foxd1+* cell is restricted to limited stromal cell types within the *Foxd1+* cortical stroma.\
(C--G′) β-gal-stained (blue) kidneys from *Foxd1*^*GCE/+*^*; R26R*^*lacZ/+*^ embryos at 19.5 dpc after injection of oil only (C and E), and 0.1 mg tamoxifen (D, F, G, and G′) at 12.5 dpc.\
(C and D) Whole-mount view. The inset in (D) shows a higher magnification of a clone in the dashed region. The arrow in (D) indicates a β-gal+ clone.\
(E and F) Sections counterstained with eosin (pink).\
(G and G′) Adjacent sections 96 μm apart showing the same clone. (G) is a higher magnification of the dashed region in (F). White arrows in (G) indicate multiple β-gal+ cells in the cortical stroma.\
a, adrenal gland; ci, renal cortical interstitium; cm, cap mesenchyme; cs, cortical stroma; k, kidney; mi, renal medullary interstitium; ms, mesangium; np, nephron precursor; nt, nephron tubule; ut, ureteric tip. Scale bars, 500 μm (C and D), 200 μm (E and F), and 50 μm in (G and G′).](gr6){#fig6}

![*Foxd1* Activity Is Dispensable for Cell-type Specification of Stromal Tissues\
Kidneys from *Foxd1*^*GC/+*^*; R26R*^*lacZ/+*^ (A, C, E, G, and I) and *Foxd1*^*GC/CE*^*; R26R*^*lacZ/+*^ (B, D, F, H, and J) embryos at 15.5 dpc.\
(A and B) β-gal-stained (blue) sections counterstained with eosin (pink).\
(C--J) Confocal immunofluorescence imaging with anti-β-gal (green) and anti-KRT (white) staining in (E)-(J). KRT is expressed in the ureteric tip and collecting duct.\
(C and D) PDFGRB (red) and WT1 (blue). Yellow arrowheads indicate β-gal+ WT1+ podocytes.\
(E and F) P57KIP2 (CDKN1C, red).\
(G and H) LIV2 (red).\
(I and J) SIX2 (red).\
cd, collecting duct; ci, renal cortical interstitium; cm, cap mesenchyme; cp, capsule; mi, renal medullary interstitium; ms, mesangium; pr, pericyte; ut, ureteric tip; ve, visceral epithelium (podocyte).\
(K) A model for cellular differentiation from mesenchymal progenitor populations during mammalian kidney development. The *Six2+* cap mesenchyme and *Foxd1+* cortical stroma are a multipotent self-renewing progenitor population for nephron epithelial and renal stromal cell types. Although *Six2+* cells differentiate into all cell types of the main body of the nephron, *Foxd1+* cortical stromal cells contribute to all stromal cells in the kidney, including cortical and medullary interstitial cells, mesangial cells, and pericytes. Only around the onset of kidney development, a small fraction of *Foxd1+* cells becomes *Six2+* cells (gray dashed arrow). Thereafter, the *Six2+* cell-derived nephron lineage and *Foxd1+* cell-derived stromal lineage form compartments with a lineage boundary throughout kidney development. Although the *Osr1+* nephrogenic mesenchyme can contribute to both *Six2+* cap mesenchyme and *Foxd1+* cortical stroma, currently, it is unclear whether a single *Osr1+* cell can differentiate into both *Six2+* and *Foxd1+* mesenchymal progenitor cells.\
Scale bars, 200 μm (A and B) and 50 μm (C--J).](gr7){#fig7}
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